Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2016 1
2017 1
2018 2
2019 3
2020 2
2021 1
2022 1
2023 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia.
Marin-Corral J, Pascual-Guardia S, Amati F, Aliberti S, Masclans JR, Soni N, Rodriguez A, Sibila O, Sanz F, Sotgiu G, Anzueto A, Dimakou K, Petrino R, van de Garde E, Restrepo MI; GLIMP investigators. Marin-Corral J, et al. Chest. 2021 Jan;159(1):58-72. doi: 10.1016/j.chest.2020.06.079. Epub 2020 Jul 17. Chest. 2021. PMID: 32687909 Free article.
[Rare location of tuberculosis: endometrial tuberculosis].
Agbodande AK, Dodo RL, Issa A, Adjadohoun S, Azon-Kouanou A, Wanvoegbe AF, Akanni MD, Prudencio R, Zannou DM, Houngbe F. Agbodande AK, et al. Among authors: dodo rl. Pan Afr Med J. 2019 May 21;33:45. doi: 10.11604/pamj.2019.33.45.17520. eCollection 2019. Pan Afr Med J. 2019. PMID: 31448008 Free PMC article. French.
Ensitrelvir treatment-emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial.
Uehara T, Yotsuyanagi H, Ohmagari N, Doi Y, Yamato M, Imamura T, Sakaguchi H, Fukushi A, Takeda Y, Baba K, Nobori H, Miyamoto T, Arita S, Dodo R, Shimba A, Fukao K, Shishido T, Tsuge Y, Mukae H. Uehara T, et al. Among authors: dodo r. Antiviral Res. 2025 Apr;236:106097. doi: 10.1016/j.antiviral.2025.106097. Epub 2025 Jan 30. Antiviral Res. 2025. PMID: 39892563 Free article. Clinical Trial.
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia.
Pascual-Guardia S, Amati F, Marin-Corral J, Aliberti S, Gea J, Soni NJ, Rodriguez A, Sibila O, Sanz F, Sotgiu G, Marcos PJ, Uranga A, Milenkovic B, Meyer CN, Kolditz M, Anzueto AR, Restrepo MI; GLIMP investigators. Pascual-Guardia S, et al. Arch Bronconeumol. 2023 Feb;59(2):90-100. doi: 10.1016/j.arbres.2022.09.005. Epub 2022 Sep 22. Arch Bronconeumol. 2023. PMID: 36376121 English, Spanish.
Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19.
Unoh Y, Hirai K, Uehara S, Kawashima S, Nobori H, Sato J, Shibayama H, Hori A, Nakahara K, Kurahashi K, Takamatsu M, Yamamoto S, Zhang Q, Tanimura M, Dodo R, Maruyama Y, Sawa H, Watari R, Miyano T, Kato T, Sato T, Tachibana Y. Unoh Y, et al. Among authors: dodo r. J Med Chem. 2025 Jul 5. doi: 10.1021/acs.jmedchem.5c00754. Online ahead of print. J Med Chem. 2025. PMID: 40616520
13 results